Treating HIV/AIDS is a lifelong commitment that demands strict adherence to drug protocols, consistent care, and a trusting relationship with health care providers.

Those of us who lived through the worst of the HIV/AIDS epidemic from the early 1980s through the mid-1990s have a very special spot in our heart for home-based health care.

I had old bunk beds that my dad got from Seabrook Farms. They were first used by German prisoners during World War II, who were sent to work the farms during the war. The metal beds with their thin mattresses could easily be used as a jungle gym and I loved them.

My family lived off the land and summer evening meals featured baked stuffed tomatoes, potato salad, corn on the cob, fresh shelled peas and homemade ice cream with strawberries from our garden. With no air conditioning in those days, the cool porch was the center of our universe after the scorching days.

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.

Over the years, HIV/AIDS activists and their allies have been pioneers in creating new frontiers in the medical establishment. Through their efforts, the FDA drug approval procedures were reformed so promising new therapies could reach desperate patients quicker.

While the behavior of the Russian government, Putin and Putin punks are abhorrent, nothing will be changed by boycotting the Sochi Winter Games. In fact, those who are appalled by the treatment of LGBT Russian citizens will lose an incredible opportunity for the world to show their disgust.